Quarterly report · Q2
3001.TEDINET S100OXKX
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥37.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.0bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥14m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥639m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥7.3bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.0bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.1bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥5.4bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥137.7bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥140.0bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥138.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥53.7bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥52.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥84.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥87.6bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥88.8bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥33.9bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.5bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥830m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥2.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥2.8bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥49.13 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.1 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.56 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥149.87 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.87 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 50.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥921m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥800m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥121m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | ¥113m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥136m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥136m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥452m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥4.3bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥4.3bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥75m |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥2.0bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥5.2bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥15m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥269m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥17.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥17.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥136m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | ¥467m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-06-30 | ¥928m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥130m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | −¥147m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | −¥147m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥567m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥5.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥5.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥521m |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥7.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥7.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥628m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥5.0bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥5.0bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥15m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥3.2bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥3.2bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥1m |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥398m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-01-01 → 2021-06-30 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-01-01 → 2021-06-30 | ¥22.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-01-01 → 2021-06-30 | ¥3.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 567
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 130000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 147000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -147000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 5036000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 7084000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 5818000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 3162000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1058000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 22161000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -147000000 | JPY |
| Net sales | Prior1YTDDuration | 22014000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 1961000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 628000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 521000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 398000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 118000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3628000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -567000000 | JPY |
| Operating income | Prior1YTDDuration | 3060000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 5142000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 3605000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 4265000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 3350000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 800000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 17164000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 17164000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 15000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 121000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 136000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -136000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 5157000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 3605000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 4265000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 3350000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 921000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 17301000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -136000000 | JPY |
| Net sales | CurrentYTDDuration | 17164000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00524-000RealEstateBusinessReportableSegmentsMember | 2004000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | -1995000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00524-000MachineryBusinessReportableSegmentsMember | 75000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00524-000TextilesBusinessReportableSegmentsMember | 269000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |